期刊文献+

环状RNA PTENP1、HIPK3在甲胎蛋白阴性的肝细胞癌患者中的表达及意义 被引量:1

Expression and significance of circular RNA PTENP1 and HIPK3 in patients with AFP negative hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨环状RNA PTENP1、HIPK3在甲胎蛋白(AFP)阴性肝细胞癌患者中的表达及临床意义。方法选择在西安大兴医院确诊的51例AFP阴性肝细胞癌患者设为肝细胞癌组,38例肝脏良性病变患者设为良性病变组,另选择35名同期健康体检者设为对照组。采用qRT-PCR法检测各组的血清PTENP1、HIPK3表达情况。结果与对照组和良性病变组比较,肝细胞癌组的血清PTENP1表达水平明显降低,而血清HIPK3表达水平明显升高,差异均有统计学意义(P均<0.05)。二元Logistic回归分析显示,血清PTENP1低表达水平和血清HIPK3高表达水平是AFP阴性肝细胞癌患者发病的独立危险因素(P<0.05)。受试者工作特征(ROC)曲线分析提示,血清PTENP1、HIPK3联合检测的受试者工作特征曲线下面积(AUC)为0.951,大于PTENP1、HIPK3单独检测的0.756、0.855(Z=4.527、P=0.000;Z=3.561,P=0.000),且联合检测可提高灵敏度和特异度(P<0.05)。结论AFP阴性肝细胞癌患者存在血清PTENP1、HIPK3异常表达,两者联合检测具有较高的临床鉴别诊断和发病风险评估价值。
作者 林涛 高春燕 许卫娜 王婷 LIN Tao;GAO Chunyan;XU Weina
出处 《国际消化病杂志》 CAS 2019年第6期424-427,共4页 International Journal of Digestive Diseases
  • 相关文献

参考文献10

二级参考文献94

  • 1黄彩云,韩素桂,张景华,杨颖,胡文俭,周秀艳,赵洪焕,刘启为,刘洪梅,马龙滨,徐康,李颖.甲胎蛋白异质体/甲胎蛋白检测联合CT扫描在原发性肝癌诊断中的价值[J].肿瘤防治研究,2014,41(2):163-165. 被引量:10
  • 2El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis andtreatment of hepatocellular carcinoma[J]. Gastroenterology,2008,134(6):1752-1763.
  • 3Venook AP, Papandreou C, Furuse J, et al. The incidence andepidemiology of hepatocellular carcinoma: a global and regionalperspective[J]. Oncologist, 2010, 15 Suppl 4: S5-13.
  • 4Shen J, Siegel AB, Remotti H, et al. Exploration of deregulatedlong nn-coding RNAs in association with hepatocarcinogenesisand survival[J]. Cancers, 2015, 7(3): 1847-1862.
  • 5Zhong Y, Yan J, Deng M, et al. Impaired phosphate and tensionhomologue deleted on chromosome 10 expression and itsprognostic role in radical surgery for hepatocellular carcinomawith family aggregation resulting from hepatitis B and livercirrhosis[J]. Exp Biol Med, 2013, 238(8): 866-873.
  • 6Vivanco I, Palaskas N, Tran C, et al. Identification of the JNKsignaling pathway as a functional target of the tumor suppressorPTEN[J]. Cancer Cell, 2007, 11(6): 555-569.
  • 7Wang T, Seah S, Loh X, et al. Simvastatin-induced breastcancer cell death and deactivation of PI3K/Akt and MAPK/ERKsignalling are reversed by metabolic products of the mevalonatepathway[J]. Oncotarget, 2015, DOI: 10.18632/oncotarget.6304[Epub ahead of print].
  • 8Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs:functional surprises from the RNA world[J]. Genes Dev, 2009,23(13): 1494-1504.
  • 9Panzitt K, Tschernatsch MM, Guelly C, et al. Characterization ofHULC, a novel gene with striking up-regulation in hepatocellularcarcinoma, as noncoding RNA[J]. Gastroenterology, 2007,132(1): 330-342.
  • 10Yuan SX, Yang F, Yang Y, et al. Long noncoding RNA associatedwith microvascular invasion in hepatocellular carcinoma promotesangiogenesis and serves as a predictor for hepatocellular carcinomapatients' poor recurrence-free survival after hepatectomy[J].Hepatology, 2012, 56(6): 2231-2241.

共引文献147

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部